RESUMEN
Bisphenol-A (BPA), an estrogenic endocrine disrupting chemical, significantly impacts numerous diseases and abnormalities in mammals. Estrogens are known to play an important role in the biology of the prostate; however, little is known about the role of bisphenols in the etiology of prostate pathologies, including benign prostate hyperplasia (BPH) and associated lower urinary tract dysfunction (LUTD). Bisphenol-F (BPF) and bisphenol-S (BPS) are analogs often used as substitutes for BPA; they are both reported to have in vitro and in vivo estrogenic effects similar to or more potent than BPA. The objective of this study was to assess the role of these bisphenols in the development of LUTD in adult male mice. In adult mice exposed to BPA, BPS or BPF, we examined urinary tract histopathology and physiological events associated with urinary dysfunction. Mice treated with bisphenols displayed increased bladder (p < 0.005) and prostate (p < 0.0001) mass, and there was an increased number of prostatic ducts in the prostatic urethra (p < 0.05) and decreased size of the urethra lumen (p < 0.05) compared to negative controls. After two months of bisphenol exposure, mice displayed notable differences in cystometric tracings compared to controls, consistent with LUTD. Treatment of male mice with all bisphenols also induced voiding dysfunction manifested by detrusor instability and histologic changes in the prostatic urethra of male rodents, consistent with LUTD. Our results implicate BPA and its replacements in the development and progression LUTD in mice and provide insights into the development and progression of BPH/LUTS in men.
Asunto(s)
Compuestos de Bencidrilo/toxicidad , Estrógenos no Esteroides/toxicidad , Fenoles/toxicidad , Hiperplasia Prostática/inducido químicamente , Enfermedades Urológicas/inducido químicamente , Animales , Compuestos de Bencidrilo/sangre , Compuestos de Bencidrilo/química , Estrógenos no Esteroides/sangre , Estrógenos no Esteroides/química , Masculino , Ratones , Ratones Endogámicos C57BL , Fenoles/sangre , Fenoles/química , Hiperplasia Prostática/sangre , Hiperplasia Prostática/patología , Enfermedades Urológicas/sangre , Enfermedades Urológicas/patologíaRESUMEN
RESEARCH QUESTION: Do bisphenol A (BPA) levels in maternal urine, serum and follicular fluid affect embryo quality and intracytoplasmic sperm hinjection (ICSI) cycle outcomes in women with unexplained infertility? DESIGN: Prospective study conducted between 1 April 2019 and 30 September 2019. The study cohort consisted of 82 women aged between 23 and 33 years who underwent intracytoplasmic sperm injection owing to unexplained infertility and provided urine, blood and follicular fluid samples on the day of oocyte retrieval. Consumption of drinking water from plastic carboys or bottles at home were considered as chronic BPA exposure. Demographic features and IVF outcomes of the patients were collected. RESULTS: Among the 82 women with unexplained infertility, clinical pregnancy was achieved in 22 (26.8%) patients after the IVF and embryo transfer cycle. The patients who consumed tap water had statistically significantly lower BPA values in three body fluids compared with patients who consumed plastic bottled water (all P < 0.001). Women who had grade 1 embryos transferred had lower serum BPA values than women who had grade 2 embryos transferred (10.8 ± 5.2 versus 26.9 ± 22 ng/ml, Pâ¯=â¯0.003). Serum and follicular fluid BPA levels were statistically significantly higher in women who failed to achieve clinical pregnancy (P < 0.001, Pâ¯=â¯0.006, respectively) and obtain a live birth (both Pâ¯=â¯0.007). CONCLUSIONS: A negative relationship was found between serum and follicular fluid BPA levels and embryo quality, clinical pregnancy and live birth in these women. In addition, the BPA levels of women who consume tap water at home were lower than those who use plastic bottled water.
Asunto(s)
Compuestos de Bencidrilo/efectos adversos , Exposición Dietética/efectos adversos , Estrógenos no Esteroides/efectos adversos , Exposición Materna/efectos adversos , Fenoles/efectos adversos , Inyecciones de Esperma Intracitoplasmáticas/estadística & datos numéricos , Adulto , Compuestos de Bencidrilo/sangre , Compuestos de Bencidrilo/orina , Agua Potable , Estrógenos no Esteroides/sangre , Estrógenos no Esteroides/orina , Femenino , Líquido Folicular/química , Humanos , Fenoles/sangre , Fenoles/orina , Embarazo , Índice de Embarazo , Estudios ProspectivosRESUMEN
Bisphenols (BPs) are commonly known plastifiers that are widely used in industry. The knowledge about the impact of BPs on thyroid function is scarce. Proper thyroid functioning is especially important for women of reproductive age, as hypothyroidism affects fertility, pregnancy outcomes and the offspring. There are no studies analyzing the influence of BPs on thyroid function and volume in non-pregnant young women. The aim of this cross-sectional study was to evaluate the relationship between bisphenol A and its 10 analogs (BPS, BPC, BPE, BPF, BPG, BPM, BPP, BPZ, BPFL, and BPBP) on thyroid function and volume in women of reproductive age. Inclusion criteria were: female sex, age 18-40 years. Exclusion criteria were history of any thyroid disease, pharmacotherapy influencing thyroid function, pregnancy or puerperium, and diagnosis of autoimmune thyroid disease during this study. Venous blood was drawn for measurement of thyrotropin (TSH), free thyroxine, thyroid peroxidase antibodies, thyroglobulin antibodies, BPs. Urine samples were analyzed for: ioduria and BPs. Ultrasound examination of thyroid gland was performed. One hundred eighty participants were included into the study. A negative correlation was found between urine BPC and the thyroid volume (R = -0.258; p = 0.0005). Patients with detected urine BPC presented smaller thyroid glands than those with not-detected urine BPC (p = 0.0008). A positive correlation was found between TSH and urine BPC (R = 0.228; p = 0.002). Patients with detected urine BPC presented higher concentrations of TSH versus those with not-detected urine BPC (p = 0.003). There were no relationships between any of serum BPs as well as the other urine BPs and thyroid function and its volume. The only BP that demonstrated the relationship between thyroid function and its volume was BPC, probably because of its chemical structure that most resembles thyroxine. Exposure to this BP may result in the development of hypothyroidism that could have a negative impact on pregnancy and the offspring.
Asunto(s)
Compuestos de Bencidrilo/efectos adversos , Compuestos de Bencidrilo/orina , Exposición Dietética/efectos adversos , Estrógenos no Esteroides/administración & dosificación , Hipotiroidismo/inducido químicamente , Exposición por Inhalación/efectos adversos , Fenoles/efectos adversos , Fenoles/orina , Adolescente , Adulto , Compuestos de Bencidrilo/sangre , Estudios Transversales , Estrógenos no Esteroides/sangre , Estrógenos no Esteroides/orina , Femenino , Humanos , Hipotiroidismo/epidemiología , Fenoles/sangre , Polonia/epidemiología , Reproducción , Absorción Cutánea , Estudiantes , Pruebas de Función de la Tiroides , Glándula Tiroides/diagnóstico por imagen , Glándula Tiroides/metabolismo , Tirotropina/sangre , Tiroxina/sangre , Ultrasonografía , Adulto JovenRESUMEN
Background Bisphenol A (BPA) is an estrogenic, endocrine-disrupting compound widely used in the industry. It is also a ubiquitous environmental pollutant. Its presence was confirmed in human fetuses, which results from maternal exposure during pregnancy. The mechanisms behind maternal-fetal transfer, and relationships between pregnant women and fetal exposures remain unclear. The aim of this study was to assess the impact of maternal exposure to BPA on the exposure of the fetus. Methods Maternal plasma and amniotic fluid samples were collected from 52 pregnant women undergoing amniocentesis for prenatal diagnosis of chromosomal abnormalities. BPA was measured by gas chromatography-mass spectrometry (GC-MS). The permeability factor - a ratio of fetal-to-maternal BPA concentration - was used as a measure delineating the transplacental transfer of BPA. Results The median concentration of maternal plasma BPA was 8 times higher than the total BPA concentration in the amniotic fluid (8.69 ng/mL, range: 4.3 ng/mL-55.3 ng/mL vs. median 1.03 ng/mL, range: 0.3 ng/mL-10.1 ng/mL). There was no direct relationship between the levels of BPA in maternal plasma and amniotic fluid levels. The permeability factor, in turn, negatively correlated with fetal development (birth weight) (R = -0.54, P < 0.001). Conclusion Our results suggest that the risk of fetal BPA exposure depends on placental BPA permeability rather than the levels of maternal BPA plasma concentration and support general recommendations to become aware and avoid BPA-containing products.
Asunto(s)
Líquido Amniótico/química , Compuestos de Bencidrilo , Peso al Nacer/efectos de los fármacos , Intercambio Materno-Fetal , Fenoles , Placenta , Adulto , Contaminantes Ocupacionales del Aire/efectos adversos , Contaminantes Ocupacionales del Aire/sangre , Contaminantes Ocupacionales del Aire/química , Compuestos de Bencidrilo/efectos adversos , Compuestos de Bencidrilo/sangre , Compuestos de Bencidrilo/química , Exposición a Riesgos Ambientales/prevención & control , Estrógenos no Esteroides/efectos adversos , Estrógenos no Esteroides/sangre , Estrógenos no Esteroides/química , Femenino , Cromatografía de Gases y Espectrometría de Masas/métodos , Humanos , Exposición Materna/prevención & control , Permeabilidad , Fenoles/efectos adversos , Fenoles/sangre , Fenoles/química , Placenta/metabolismo , Placenta/fisiopatología , Embarazo , Segundo Trimestre del EmbarazoRESUMEN
Evaluating the biological significance of human-relevant exposures to environmental estrogens involves assessing the individual and total estrogenicity of endogenous and exogenous estrogens found in serum, for example from biomonitoring studies. We developed a method for this assessment by integrating approaches for (i) measuring total hormone concentrations by mass spectrometry (Fleck et al., 2018), (ii) calculating hormone bioavailable concentrations in serum and, (iii) solving multiple equilibria between estrogenic ligands and receptors, and (iv) quantitatively describing key elements of estrogen potency. The approach was applied to endogenous (E1, E2, E3, E4), environmental (BPA), and dietary Genistein (GEN), Daidzein (DDZ) estrogens measured in the serum of thirty pregnant women. Fractional receptor occupancy (FRO) based estrogenicity was dominated by E1, E2 and E3 (ER-α, 94.4-99.2% (median: 97.3%), ER-ß, 82.7-97.7% (median: 92.8%), as was the total response (TR), which included ligand specific differences in recruitment of co-activator proteins (RCA). The median FRO for BPA was at least five orders of magnitude lower than E1, E2 and E3, and three orders of magnitude lower than the fetal derived E4 and GEN and DDZ. BPA contributed less than 1/1000th of the normal daily variability in total serum estrogenicity in this cohort of pregnant women.
Asunto(s)
Contaminantes Ambientales/sangre , Estrógenos no Esteroides/sangre , Receptores de Estrógenos/metabolismo , Adolescente , Adulto , Compuestos de Bencidrilo/sangre , Compuestos de Bencidrilo/metabolismo , Compuestos de Bencidrilo/farmacocinética , Disponibilidad Biológica , Estudios de Cohortes , Monitoreo del Ambiente/métodos , Contaminantes Ambientales/metabolismo , Contaminantes Ambientales/farmacocinética , Estrenos/sangre , Estrenos/metabolismo , Estrenos/farmacocinética , Estrógenos no Esteroides/metabolismo , Estrógenos no Esteroides/farmacocinética , Femenino , Genisteína/sangre , Genisteína/metabolismo , Genisteína/farmacocinética , Humanos , Isoflavonas/sangre , Isoflavonas/metabolismo , Isoflavonas/farmacocinética , Ligandos , Modelos Biológicos , Fenoles/sangre , Fenoles/metabolismo , Fenoles/farmacocinética , Embarazo , Adulto JovenRESUMEN
BACKGROUND: This meta-analytic study explored the relationship between the risk of type 2 diabetes mellitus (T2DM) and bisphenol A concentrations. METHODS: The Embase and Medline (PubMed) databases were searched, using relevant keywords, for studies published between 1980 and 2018. A total of 16 studies, twelve cross-sectional, two case-control and one prospective, were included in the meta-analysis. The odds ratio (OR) and its 95% confidence interval (CI) were determined across the sixteen studies. The OR and its 95% CI of diabetes associated with bisphenol A were estimated using both fixed-effects and random-effects models. RESULTS: A total of 41,320 subjects were included. Fourteen of the sixteen studies included in the analysis provided measurements of urine bisphenol A levels and two study provided serum bisphenol A levels. Bisphenol A concentrations in human bio-specimens showed positive associations with T2DM risk (OR 1.28, 95% CI 1.14, 1.44). A sensitivity analysis indicated that urine bisphenol A concentrations were positively associated with T2DM risk (OR 1.20, 95% CI 1.09, 1.31). CONCLUSIONS: This meta-analysis indicated that Bisphenol A exposure is positively associated with T2DM risk in humans.
Asunto(s)
Compuestos de Bencidrilo/efectos adversos , Glucemia/metabolismo , Diabetes Mellitus Tipo 2/inducido químicamente , Exposición a Riesgos Ambientales/efectos adversos , Estrógenos no Esteroides/efectos adversos , Fenoles/efectos adversos , Compuestos de Bencidrilo/sangre , Compuestos de Bencidrilo/orina , Glucemia/efectos de los fármacos , Estudios de Casos y Controles , Estudios Transversales , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/orina , Estrógenos no Esteroides/sangre , Estrógenos no Esteroides/orina , Humanos , Fenoles/sangre , Fenoles/orinaRESUMEN
The environmental estrogen, zearalenone (ZEA), is found in the food supply from Fusarium fungal contamination in grains and sometimes used as a growth promoter for beef cattle. Long-term exposure to ZEA and its metabolites may present health risk due to higher estrogenic activity. Serum ZEA metabolites were measured to determine the exposure and the association with food intake in 48 overweight/obese women (52⯱â¯9 years). The free and conjugated ZEA indicated the highest detection rate of all the metabolites. Conjugated ZEA and total ZEA metabolites were lower (pâ¯=â¯0.02) in overweight/obese than normal weight women, and free metabolites were either the same or showed a trend to be higher. In addition, those with highest (280-480â¯g/d) compared those with lowest (<115â¯g/d) meat consumption had higher conjugated serum ZEA metabolite concentrations (pâ¯<â¯0.05). Intakes of other food groups (i.e., dairy, cereal, etc.) were not associated with ZEA metabolites. These findings indicate that ZEA and its metabolites are detectable in nearly all women and concentrations are associated with greater meat intake, and influenced by body mass index. Determining how the food supply influences human concentrations of ZEA metabolites is warranted, as well as determining vulnerable populations.
Asunto(s)
Índice de Masa Corporal , Ingestión de Energía , Estrógenos no Esteroides/sangre , Zearalenona/sangre , Adulto , Cromatografía Liquida , Dieta , Estrógenos no Esteroides/metabolismo , Femenino , Abastecimiento de Alimentos , Humanos , Límite de Detección , Productos de la Carne , Menopausia , Persona de Mediana Edad , Obesidad/metabolismo , Sobrepeso/metabolismo , Espectrometría de Masas en Tándem , Zearalenona/metabolismoRESUMEN
There is increasing concern about possible adverse effects of soy based infant formulas (SBIF) due to their high amount of isoflavones (ISO). The aim of the present study was to investigate effects of neonatal exposure to ISO on reproductive system of female Wistar rats. Animals were exposed to an ISO depleted diet or a diet enriched with an ISO extract (IRD; 508mg ISO/kg) during embryogenesis and adolescence. Pups of each group were fed daily by pipette with ISO-suspension (ISO+; 32mg ISO/kg bw) or placebo from postnatal day (PND) 1 until PND23 resulting in plasma concentrations similar to levels reported in infants fed SBIF. The visceral fat mass was reduced by long-term IRD. Vaginal epithelial height was increased at PND23 and vaginal opening was precocious in ISO+ groups. Later in life, more often irregular estrus cycles were observed in rats of ISO+ groups. In addition, FSH levels and uterine epithelial heights were increased at PND80 in ISO+ groups. In summary, the results indicate that neonatal ISO intake, resulting in plasma concentrations achievable through SBIF, has an estrogenic effect on prepubertal rats and influences female reproductive tract later in life.
Asunto(s)
Estrógenos no Esteroides/toxicidad , Isoflavonas/toxicidad , Reproducción/efectos de los fármacos , Animales , Animales Recién Nacidos , Desarrollo Embrionario/efectos de los fármacos , Estrógenos no Esteroides/sangre , Ciclo Estral/efectos de los fármacos , Femenino , Genitales Femeninos/efectos de los fármacos , Genitales Femeninos/crecimiento & desarrollo , Crecimiento/efectos de los fármacos , Humanos , Lactante , Alimentos Infantiles , Grasa Intraabdominal/efectos de los fármacos , Isoflavonas/sangre , Ratas , Ratas Wistar , Maduración Sexual/efectos de los fármacos , Glycine max , Vagina/anatomía & histología , Vagina/efectos de los fármacosRESUMEN
Despite its very low oral bioavailability and rapid elimination, multiple reports of unexpectedly high bisphenol A (BPA) concentrations in the serum of pregnant mothers or cord blood have raised questions about BPA exposures during pregnancy. Thirty healthy pregnant women recruited to the study were evaluated for total BPA exposure over a 30-h period comprising one-half day in the field and one day in a clinical setting. BPA and its metabolites were measured in serum and total BPA was measured in matching urine samples. The mean total exposure was similar to the 50(th) percentile of exposure for U.S. women and pregnant women in a large North American cohort. Twenty volunteers had total daily exposures equal to or exceeding the U.S. mean, and six volunteers had exposures exceeding the 75th percentile. Women working as cashiers did not have higher total BPA exposure. BPA was detected in some serum samples (0.25-0.51 ng/ml), but showed no relationship to total BPA in corresponding urine samples, no relationship to total BPA exposure, and had unconjugated BPA fractions of 60-80%, consistent with established criteria for sample contamination. We conclude that typical exposures of North American pregnant women produce internal exposures to BPA in the picomolar range.
Asunto(s)
Compuestos de Bencidrilo/farmacocinética , Exposición a Riesgos Ambientales , Contaminantes Ambientales/farmacocinética , Estrógenos no Esteroides/farmacocinética , Contaminación de Alimentos/análisis , Fenoles/farmacocinética , Adolescente , Adulto , Compuestos de Bencidrilo/sangre , Compuestos de Bencidrilo/orina , Contaminantes Ambientales/sangre , Contaminantes Ambientales/orina , Estrógenos no Esteroides/sangre , Estrógenos no Esteroides/orina , Femenino , Humanos , Límite de Detección , Fenoles/sangre , Fenoles/orina , Embarazo , Distribución Tisular , Adulto JovenRESUMEN
AIM: To explore the effect of phenolic environmental estrogens (EE) on women with uterine leiomyoma (UL). METHODS: Urine and blood plasma samples were collected from 300 patients diagnosed with UL at the Affiliated Zhongda Hospital of Southeast University between December 2013 and December 2014. Control urine and blood plasma samples were collected from 300 women who are either patients without UL or healthy volunteers presenting to the same hospital for physical examination during the same period. Bisphenol A (BPA), nonylphenol (NP) and octylphenol (OP) concentration in these samples was measured using solid phase extraction (SPE) coupled with liquid chromatography-tandem mass spectrometry. RESULTS: The OP concentration in urine and blood plasma was significantly higher in the UL group compared with the control group (r = 0.224, P = 0.001). Urine BPA concentration was not significantly different between the UL group and the control group (r = 0.009, P = 0.896). There was also no statistically significant difference in urine NP concentration between the two groups (r = 0.057, P = 0.419). On logistic regression, exposure concentration of urine BPA (OR, 1.129; 95%CI: 1.081-1.179) and NP (OR, 1.165; 95%CI: 1.025-1.324) was associated with UL genesis (P < 0.05). Nevertheless, there was no significant difference in blood plasma concentration of BPA, OP and NP between the two groups (P > 0.05). CONCLUSION: Urine and blood plasma EE exposure levels in women, especially the urine level, was related to the incidence of UL.
Asunto(s)
Exposición a Riesgos Ambientales/análisis , Estrógenos no Esteroides/sangre , Estrógenos no Esteroides/orina , Leiomioma/epidemiología , Neoplasias Uterinas/epidemiología , Adulto , Compuestos de Bencidrilo/sangre , Compuestos de Bencidrilo/orina , China/epidemiología , Cromatografía Líquida de Alta Presión , Femenino , Humanos , Leiomioma/sangre , Leiomioma/orina , Persona de Mediana Edad , Fenoles/sangre , Fenoles/orina , Extracción en Fase Sólida , Espectrometría de Masas en Tándem , Neoplasias Uterinas/sangre , Neoplasias Uterinas/orinaRESUMEN
Over 50% of the causes of fetal malformations in humans are still unknown. Recent evidence suggests the relationship between environmental exposure to endocrine disruptors and fetal malformations. Our study aims to establish the role of Bisphenol A (BPA), if any, in altering human reproduction. We enrolled 151 pregnant women who were divided into two groups: case group (CS, n=101), women with established diagnosis of developmental defect, and control group (CL, n=50), pregnant women with normally developed fetus. Total, free and conjugated BPA were measured in their blood using GC-MS with isotopic dilution. The results show a correlation between environmental exposure to BPA and the genesis of fetal malformations. Conjugated BPA, which was higher in the CL, casts light on the hypothesis that a reduced ability to metabolize the chemical in the mother can concur to the occurrence of malformation. In a more detailed manner, in case of chromosomal malformations, the average value of free BPA appears to be nearly three times greater than that of the controls. Similarly, in case of central and peripheral nervous system non-chromosomal malformations, the value of free BPA is nearly two times greater than that of the controls.
Asunto(s)
Compuestos de Bencidrilo/envenenamiento , Anomalías Congénitas/etiología , Feto/efectos de los fármacos , Exposición Materna/efectos adversos , Fenoles/envenenamiento , Adulto , Compuestos de Bencidrilo/sangre , Aberraciones Cromosómicas/efectos de los fármacos , Anomalías Congénitas/sangre , Estrógenos no Esteroides/sangre , Estrógenos no Esteroides/envenenamiento , Femenino , Feto/anomalías , Cromatografía de Gases y Espectrometría de Masas , Humanos , Fenoles/sangre , EmbarazoRESUMEN
We measured serum dBPA in non-pregnant and pregnant female rhesus monkeys, fetuses and amniotic fluid. dBPA was administered by a daily oral bolus or sc implantation of Silastic capsules; both resulted in daily average serum unconjugated dBPA concentrations of <1ng/ml. We observed lower serum concentrations of unconjugated dBPA in pregnant females relative to pre-pregnancy values, and generally lower concentrations in fetal serum than in maternal serum. Differences in pharmacokinetics of dBPA were evident between pre-pregnancy, early and late pregnancy, likely reflecting changes in maternal, fetal and placental physiology. The serum ratio of conjugated to unconjugated dBPA after continuous sc release of dBPA was similar to values reported in human biomonitoring studies and markedly lower than with oral administration, suggesting oral bolus exposure is not an appropriate human exposure model. We report elsewhere that there were numerous adverse effects on fetuses exposed to very low serum dBPA in these studies.
Asunto(s)
Compuestos de Bencidrilo/farmacocinética , Estrógenos no Esteroides/farmacocinética , Fenoles/farmacocinética , Embarazo/metabolismo , Administración Oral , Animales , Compuestos de Bencidrilo/administración & dosificación , Compuestos de Bencidrilo/sangre , Compuestos de Bencidrilo/química , Cápsulas , Dimetilpolisiloxanos/química , Exposición a Riesgos Ambientales , Estrógenos no Esteroides/administración & dosificación , Estrógenos no Esteroides/sangre , Estrógenos no Esteroides/química , Femenino , Humanos , Macaca mulatta , Intercambio Materno-Fetal , Fenoles/administración & dosificación , Fenoles/sangre , Fenoles/química , Embarazo/sangreRESUMEN
OBJECTIVE: We compared the pharmacokinetic (PK) profiles of diethylstilbestrol orally dissolving film (DES ODF) and DES-capsule as well as assessing the safety, local tolerability, taste, and disintegration time of DES ODF. MATERIALS AND METHODS: Twelve healthy male volunteers receiving a single administration of 2.0 mg of DES ODF or DES-capsule were included in the study. The tolerability, taste, and time to dissolution of DES ODF were assessed after dosing. Safety assessments included adverse events, hematology and biochemistry tests, urinalysis, vital signs, and electrocardiography. RESULTS: The PK parameters of DES ODF were all greater than those of DEScapsule. The Cmax values were 5.64 ± 1.1 and 3.4 ± 1.93 ng/mL for DES ODF and DES-capsule, respectively. Assessment of bioequivalence was based on the 90% CIs of the treatment ratios of the log-transformed Cmax, AUC0-t, and AUC0-∞ (DES ODF to DES-capsule), with the mean values being 1.93 (141 - 264), 1.24 (98 - 156), and 1.59 (121 - 207), respectively, indicating that DES ODF had a significantly high bioavailability. The mean DES ODF disintegration time was 14 ± 5 minutes. DES ODF was well tolerated and no serious adverse events or clinically relevant changes were observed. CONCLUSIONS: The DES ODF is well tolerated and better absorbed in comparison with DES-capsule.
Asunto(s)
Dietilestilbestrol/farmacocinética , Estrógenos no Esteroides/farmacocinética , Administración Oral , Adulto , Área Bajo la Curva , Disponibilidad Biológica , Cápsulas , China , Estudios Cruzados , Dietilestilbestrol/administración & dosificación , Dietilestilbestrol/efectos adversos , Dietilestilbestrol/sangre , Dietilestilbestrol/química , Estrógenos no Esteroides/administración & dosificación , Estrógenos no Esteroides/efectos adversos , Estrógenos no Esteroides/sangre , Estrógenos no Esteroides/química , Semivida , Voluntarios Sanos , Humanos , Masculino , Tasa de Depuración Metabólica , Factores Sexuales , Solubilidad , Gusto , Equivalencia Terapéutica , Adulto JovenRESUMEN
We determined bisphenol A (BPA) concentrations of 61 pregnant women (PW), their fetuses and 26 nonpregnant women (NPW) in Eastern Townships of Canada; and evaluated potential correlations between maternal and fetal blood, and between peripheral blood and peritoneal fluid. In PW, BPA levels were ranged from non-detected to 4.46ng/ml and from non-detected to 4.60ng/ml for maternal and fetal serum, respectively. In NPW, BPA levels were ranged from 1.30 to 8.17ng/ml and from 0.19 to 13.45ng/ml for serum and peritoneal fluid, respectively. Positive correlation was found between maternal and fetal serum, and between serum and peritoneal fluid. In conclusion, our findings highlight a continuous distribution of BPA between the mother and its fetus and reveal a role of pregnancy in underestimating the actual levels of blood BPA. Our study also provides a temporal-spatial reference on BPA exposure, which is a useful tool in monitoring, comparing and correcting.
Asunto(s)
Líquido Ascítico/química , Compuestos de Bencidrilo/sangre , Contaminantes Ambientales/sangre , Estrógenos no Esteroides/sangre , Sangre Fetal/química , Fenoles/sangre , Adulto , Monitoreo del Ambiente , Femenino , Humanos , Recién Nacido , Masculino , Exposición Materna , Intercambio Materno-Fetal , EmbarazoRESUMEN
Identification of maternal environmental factors influencing preterm birth risks is important to understand the reasons for the increase in prematurity since 1990. Here, we utilized a health survey, the US National Health and Nutrition Examination Survey (NHANES) to search for personal environmental factors associated with preterm birth. 201 urine and blood markers of environmental factors, such as allergens, pollutants, and nutrients were assayed in mothers (range of N: 49-724) who answered questions about any children born preterm (delivery <37 weeks). We screened each of the 201 factors for association with any child born preterm adjusting by age, race/ethnicity, education, and household income. We attempted to verify the top finding, urinary bisphenol A, in an independent study of pregnant women attending Lucile Packard Children's Hospital. We conclude that the association between maternal urinary levels of bisphenol A and preterm birth should be evaluated in a larger epidemiological investigation.
Asunto(s)
Compuestos de Bencidrilo/orina , Contaminantes Ambientales/orina , Estrógenos no Esteroides/orina , Exposición Materna/efectos adversos , Fenoles/orina , Nacimiento Prematuro/etiología , Adulto , Compuestos de Bencidrilo/sangre , Monitoreo del Ambiente , Contaminantes Ambientales/sangre , Estrógenos no Esteroides/sangre , Femenino , Humanos , Encuestas Nutricionales , Fenoles/sangre , Embarazo , Adulto JovenRESUMEN
OBJECTIVES: To investigate the effect of phenolic environmental estrogens on uterine leiomyoma from the perspective of clinical epidemiology. METHODS: Urine and blood samples were collected from Han women with uterine leiomyoma and women without uterine leiomyoma, living in Nanjing, China, between September 2011 and February 2013. A total of 156 urine samples and 214 blood samples were collected from the uterine leiomyoma group and 106 urine samples and 126 blood plasma samples from the control group. Bisphenol A (BPA), nonylphenol (NP) and octylphenol (OP) concentrations were determined by solid-phase extraction (SPE) coupled with liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). RESULTS: Phenolic environmental estrogens in the uterine leiomyoma and control groups were compared based on: gravida>3 and gravida ≤ 3. In participants with gravida>3, urine OP concentration was significantly (P<0.05) higher in the uterine leiomyoma group than in the control group. In participants with gravida ≤ 3, urine NP concentration was significantly (P<0.05) higher in the uterine leiomyoma group compared to controls. Despite obstetric history, urine BPA mean exposure concentration was significantly (P<0.05) different between uterine leiomyoma group and control group. The urine BPA concentration was not significantly (P>0.05) different between gravida>3 and gravida ≤ 3 patients. There was no significant (P>0.05) difference in plasma concentrations of BPA, OP and NP between the leiomyoma group and control group. Mean exposure concentration and range of distribution of BPA, OP and NP plasma concentration differed between the uterine leiomyoma and control group. CONCLUSION: Exposure level of phenolic environmental estrogens in human was related with leiomyoma tumorigenesis.
Asunto(s)
Estrógenos no Esteroides/metabolismo , Leiomioma/epidemiología , Leiomioma/metabolismo , Fenoles/metabolismo , Neoplasias Uterinas/epidemiología , Neoplasias Uterinas/metabolismo , Compuestos de Bencidrilo , Estudios de Casos y Controles , Cromatografía Liquida , Exposición a Riesgos Ambientales , Estrógenos no Esteroides/sangre , Estrógenos no Esteroides/orina , Femenino , Humanos , Fenoles/sangre , Fenoles/orina , Espectrometría de Masas en TándemRESUMEN
Mammalian estrogen receptors modulate many physiological processes. Chemicals with structural features similar to estrogens can interact with estrogen receptors to produce biological effects similar to those caused by endogenous estrogens in the body. Bisphenol A (BPA) is a structural analogue of estrogen that binds to estrogen receptors. Exposure to BPA in humans is virtually ubiquitous in industrialized societies, but BPA is rapidly detoxified by metabolism and does not accumulate in the body. Whether or not serum concentrations of BPA in humans are sufficiently high to disrupt normal estrogen-related biology is the subject of intense political and scientific debate. Here we show a convergence of robust methods for measuring or calculating serum concentrations of BPA in humans from 93 published studies of more than 30,000 individuals in 19 countries across all life stages. Typical serum BPA concentrations are orders of magnitude lower than levels measurable by modern analytical methods and below concentrations required to occupy more than 0.0009% of Type II Estrogen Binding Sites, GPR30, ERα or ERß receptors. Occupancies would be higher, but ≤0.04%, for the highest affinity receptor, ERRγ. Our results show limited or no potential for estrogenicity in humans, and question reports of measurable BPA in human serum.
Asunto(s)
Compuestos de Bencidrilo/sangre , Compuestos de Bencidrilo/toxicidad , Exposición a Riesgos Ambientales/análisis , Fenoles/sangre , Fenoles/toxicidad , Adulto , Compuestos de Bencidrilo/metabolismo , Estrógenos no Esteroides/sangre , Femenino , Hospitales , Humanos , Lactante , Fenoles/metabolismo , Receptores de Estrógenos/metabolismoRESUMEN
A rapid, sensitive and accurate method for the simultaneous determination of six phenolic environmental estrogens, i. e., bisphenol A (BPA), diethylstilbestrol (DES), dienestrol( DE), hexestrol (HEX), 4-( tert-octyl)-phenol (4-tOP) and 4-nonylphenol (4-NP) in bullfrog blood by dispersive solid-phase extraction-ultrafast liquid chromatography-tandem mass spectrometry (dSPE-UFLC-MS/MS) was established. After protein precipitation, bullfrog blood samples were cleaned-up by dSPE method with ethylenediamine-functionalized Fe3O4, magnetic polymers (EDA-MPs) as adsorbent. The effects of precipitation solvents, adsorption time and the amount of EDA-MPs used on the recoveries of six phenolic environmental estrogens were investigated in detail. Chromatographic separation was performed on a Shim-pack XR-ODS II analytical column (100 mm x 2.0 mm, 2.2 microm). The mass spectrometer was operated by using electrospray ion (ESI) source in the multiple reaction monitoring (MRM) mode. The results showed that the linearities were in the range of 0.5-100.0 microg/L with correlation coefficients (r2) not less than 0.999 6 for all the six phenolic environmental estrogens. The lim- its of quantification (LOQs) (S/N > 10) in bullfrog blood samples were between 0. 075 microg/L and 0.40 microg/L. The recoveries were between 95.0% and 110.0% at three spiked levels. The precision values expressed as relative standard deviations (RSDs) were in the range of 0.6%-6.3%. The developed method can be applied to the routine analysis of the six phenolic environmental estrogens in bullfrog blood samples.
Asunto(s)
Cromatografía Liquida/métodos , Contaminantes Ambientales/sangre , Estrógenos no Esteroides/sangre , Fenoles/sangre , Espectrometría de Masas en Tándem/métodos , Animales , Compuestos de Bencidrilo/sangre , Dienestrol/sangre , Dietilestilbestrol/sangre , Rana catesbeiana/sangre , Extracción en Fase Sólida/métodosRESUMEN
Bisphenol A (BPA) is an important industrial chemical used as the monomer for polycarbonate plastic and in epoxy resins for use in food can liners. Worldwide biomonitoring studies consistently find high prevalence of BPA conjugates in urine consistent with pervasive exposure at levels typically below 1 µg/kg bw/day. The current study used LC/MS/MS to measure serum pharmacokinetics of unconjugated (active) and conjugated (inactive) BPA in adult female CD-1 mice following intravenous (IV) injection, which produces higher serum levels by circumventing the processes of absorption from the GI tract and presystemic metabolism that occur after oral administration. Deuterated BPA (100 µg/kg bw) was used to avoid interference by background contamination from trace amounts of native BPA. Additionally, the pharmacokinetics of unconjugated BPA were determined in adipose tissue, a proposed site of action and "depot" for BPA. After IV injection, unconjugated BPA rapidly distributed out of the circulation (t(1/2)=0.2 h) and terminal elimination also proceeded rapidly (t(1/2)=0.8 h). Consistent with the degree of aqueous solubility, lipid/water solubility ratio, and partitioning from blood into adipose tissue in vivo, the levels of unconjugated BPA in mouse adipose tissue rapidly reached a maximal level (0.25 h) that did not exceed the serum maximum at the initial sampling time (0.08 h). Terminal elimination of unconjugated BPA from adipose tissue (t(1/2)=7.0 h) was similar to that for conjugated BPA in serum (t(1/2)=6.6 h) and <0.01% of the administered dose remained in adipose tissue after 24 h. These plasma and tissue kinetics are consistent with rapid equilibria and underscore the non-persistent nature of BPA, particularly when compared with slowly metabolized lipophilic organic pollutants like halogenated dibenzodioxins.
Asunto(s)
Estrógenos no Esteroides/farmacocinética , Grasa Intraabdominal/metabolismo , Fenoles/farmacocinética , Animales , Compuestos de Bencidrilo , Cromatografía Liquida , Estrógenos no Esteroides/administración & dosificación , Estrógenos no Esteroides/sangre , Femenino , Semivida , Inyecciones Intravenosas , Ratones , Fenoles/administración & dosificación , Fenoles/sangre , Espectrometría de Masas en TándemRESUMEN
Here we assess bisphenol A (BPA) in couples undergoing in vitro fertilization (IVF) and indicators of embryo quality; embryo cell number (ECN) and embryo fragmentation score (EFS). Twenty-seven couples provided serum on the day of oocyte retrieval. Unconjugated BPA was measured by HPLC with Coularray detection. Odds ratios (OR) were generated using ordinal logistic regression including female and male BPA concentrations, age and race, and day of embryo transfer for ECN. Inverse associations are suggested for male BPA with ECN (OR=0.70, P=0.069), and EFS (OR=0.54, P=0.009), but not for women. Male BPA exposure may affect embryo quality during IVF.